Spatial Biology – News and Features

The data collected on VTX-2337 supports its potential as an immunotherapeutic approach in cancer. The preclinical data published in Clinical Cancer Research also underscores important differences between TLRs in human immune responses.

Innovative research begins new era of mass spectrometry-based single-cell measurements to enhance understanding of the growth, proliferation and differentiation of cells.

Partnership forged to tackle tumor heterogeneity.

In this article researchers from the University of Arizona review several promising system integration approaches for microfluidics and discuss their advantages, limitations and applications.

Delivers exclusive distribution rights for IntelliCyt's full line of instrumentation, informatics software, and assay kit products.

In this role, Mr. Watson will lead the company’s global marketing and strategy efforts to grow the current commercial targeted sequencing business and prepare the market for the launch of its digital PCR and single cell analysis products.

Total revenue for the first quarter of 2011 was $8.7 million, an increase of 30% from $6.7 million in the first quarter of 2010.

OSU’s Li disrupts cellular messages through fragment-based drug design.

FOXO3 gene suppresses activation of cells related to immunity and thus leads to a reduced immune response against a growing cancer.

A new study of prostate tumors has shown that a gene, FOXO3, suppresses activation of cells related to immunity and thus leads to a reduced immune response against a growing cancer.